Analyst Sees Potential for Omeros' (OMER) OMS824 as FDA Gives Clearance
Tweet Send to a Friend
Wedbush today reiterated an Outperform rating on Omeros Corp. (NASDAQ: OMER) with a price target of $18.00. Comments follow news ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


